Clinical Trial Update: AMEND TS Early Feasibility Study [NA]

View source ↗

Summary

AMEND TS early feasibility study sponsored by Valcare Medical Ltd. is currently recruiting for symptomatic functional mitral regurgitation grade 3 or greater.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Mitral Regurgitation

Snippet

Sponsor: Valcare Medical Ltd. | Conditions: Symptomatic Functional MR 3 or Greater | NA | Status: RECRUITING